The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Please provide your email address to receive an email when new articles are posted on . Implantable loop recorder screening for atrial fibrillation did not significantly reduce the risk for stroke ...

Using an implantable loop recorder (ILR) to screen older individuals for atrial fibrillation (AF) may be more beneficial when NT-proBNP levels are high, according to a post hoc analysis of the LOOP ...

Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation ...